There has been much interest in the potential role of soy in reducing the risk of chronic diseases. Soy foods are uniquely rich in isoflavones, a fact that has triggered much research including intervention studies. However, there have been few long-term prospective observational studies that include disease itself as an outcome. High intake of soy foods is intrinsic to the Japanese diet, which can be advantageous for conducting such studies in Japan. The present report reviews the findings from Japanese prospective cohort studies on soy intake and the risk of cardiovascular diseases, cancer, type 2 diabetes, osteoporosis, menopausal symptoms, and dementia. The results suggest a beneficial role of soy in several chronic diseases, but they are not without controversy. Discrepancies have been observed in the findings of studies of Japanese or other Asians as compared to those of non Asians. This review discusses the issues to be explored in future studies.
Subscribe to Journal
Get full journal access for 1 year
only $33.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Murphy PA, Barua K, Hauck CC. Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Anal Technol Biomed Life Sci. 2002;777:129–38.
Pabich M, Materska M. Biological effect of soy isoflavones in the prevention of civilization diseases. Nutrients. 2019;11. https://doi.org/10.3390/nu11071660.
Miyazaki K. Novel approach for evaluation of estrogenic and anti-estrogenic activities of genistein and daidzain using B16 melanoma cells and dendricity assay. Pigment Cell Res. 2004;17:407–12.
Zhu Y, Yao Y, Shi Z, Everaert N, Ren G. Synergic effect of bioactive anticarcinogens from soybean on anti-proliferative activity in MDA-MB-231 and MCF-7 human breast cancer cells in vitro. Nutrients. 2018;23:1557.
Kojima K, Asai K, Kubo H, Sugitani A, Kyomoto Y, Okamoto A, et al. Isoflavone aglycones attenuate cigarette smoke-induced emphysema via suppression of neurotrophilic inflammation in a COPD murine model. Nutrients. 2019;11:2023.
Rabiau N, Kossai M, Braud M, Chalabi N, Satih S, Bignon YJ, et al. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol. 2010;34:200–6.
Choi MS, Lee MK, Jung UJ, Kim HJ, Do GM, Park YB, et al. Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet. Mol Nutr Food Res. 2009;53:751–9.
Lu Y, An Y, Lv C, Ma W, Xi Y, Xiao R. Dietary soy bean isoflavones in Alzheimer’s disease prevention. Asia Pac J Clin Nutr. 2018;27:946–54.
Matori H, Umar S, Nadadur RD, Sharma S, Partow-Navid R, et al. Genistein, a soy phytoestrogen, revers pulmonary hypertention and prevents right heart failure in rats. Hypertension. 2012;60:425–30.
Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab. 2001;86:41–7.
Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr. 2004;134:522–9.
Kingsley K, Truong K, Low E, Hill CK, Chokshi SB, Phipps D, et al. Soy protein extract (spe) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines. J Diet. 2011;8 Suppl:169–88.
Kobayashi H. Prevention of cancer and inflammation by soybean inhibitors. Front Biosci. 2013;E5:966–73.
The National Health and Nutrition Survey in Japan, 2017. Ministry of Health, Labour, and Welfare, Japan, 2018.
Bai W, Wang C, Ren C. Intakes of total and individual flavonoids by US adults. Int J Food Sci Nutr. 2014;65:9–20.
Mulligan AA, Kuhnle GGC, Lentjes MAH, van Scheltinga V, Powell NA, McTaggart A, et al. Intakes and sources of isoflavones, lignans, enterolignans, coumestrol and soya-containing foods in the Norfolk arm of the European prospective Investigation into Cancer and Nutrition (EPIC-Norfolk), from 7 d food diaries, using a newly updated database. Public Health Nutr. 2012;16:1454–62.
Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y, et al. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer. 1999;33:139–45.
Zamora-Ros R, Knaze V, Lujian-Barroso L, Kuhnle GGC, Mulligan AA, Touillaud M, et al. Dietary intakes and food sources of phytoestrogens in the European Prospective Onvestigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur J Clin Nutr. 2012;66:932–41.
Kim K, Vance TM, Chun OK. Estimated intake and major food soutces of flavonoids among US adults; changes between 1999-2002 and 2007-2010 in NHANES. Eur J Nutr. 2016;55:833–43.
Hirayama T. Life-style and mortality: a large-scale census-based cohort study in Japan. Basel, Switzerland: Karger; 1990.
Ozasa K, Grant EJ, Kodama K. Japanese legacy cohorts: the Life Span Study atomic survivor cohort and survivors’ offspring. J Epidemiol. 2018;28:162–9.
Sauvaget C, Lagarde F, Nagano J, Soda M, Koyama K, Kodama K. Lifestyle factors, radiation and gastric cancer in atomic-bomb survivors (Japan). Cancer Causes Control. 2005;16:773–80.
Nippon data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese. J Hum Hypertens. 2003;17:851–7.
Khan MMH, Goto R, Kobayashi K, Suzumura S, Nagata Y, Sonoda T, et al. Dietary habits and cancer mortality among middle aged and older Japanese living in Hokkaido, Japan by cancer site and sex. Asian Pac J Cancer Prev. 2004;5:58–65.
Mizoue T, Tokui N, Nishisaka K, Nishisaka S, Ogimoto I, Ikeda M, et al. Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol. 2000;29:232–7.
Sekita A, Ninomiya T, Tanizaki Y, Doi Y, Hata J, Yonemoto K, et al. Trends in prevalence of Alzheimer’s disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand. 2010;122:319–23.
Tamakoshi A, Yoshimura T, Inaba Y, Ito Y, Watanabe Y, Fukuda K, et al. Profile of the JACC study. J Epidemiol. 2005;15 Suppl 1:S4–8.
Tsugane S, Sawada N. The JPHC study design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014;44:777–82.
Shimizu H. The basic report on Takayama Study. Gifu, Japan: Department of Public Health, Gifu University School of Medicine; 1996.
Ishikawa S, Gotoh T, Nago N, Kayaba K. The Jichi Medical School (JMS) cohort study: design, baseline data and standardized mortality ratios. J Epidemiol. 2002;12:408–17.
Iki M, Tamaki J, Sato Y, Morita A, Ikeda Y, Kajita E, et al. Cohort profile: the Japanese population-based Osteoporosis (JPOS) Cohort Study. Int J Epidemiol. 2015;44:405–14.
Shimokata H, Ando F, Niino N. A new comprehensive study on aging—the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol. 2000;10 1 Suppl:S70–6.
Kuriyama S, Nakaya N, Ohmori-Matuda K, Shimazu T, Kikuchi N, Kakizaki M, et al. The Ohsaki cohort 2006 study: design of study and profile of participants at baseline. J Epidemiol. 2010;20:253–8.
Tatsumi Y, Morimoto A, Deura K, Mizuno S, Ohno Y, Watanabe S. Effects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: the Saku study. J Diabetes Investig. 2013. https://doi.org/10.1111/jdi.12100.
Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, et al. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine Isoflavones. J Nutr. 2001;131:2741–7.
Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer. 2002;87:31–6.
Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations. The Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116:2553–62.
Yamazaki K, Kayaba K, Ishikawa S. Soy and soy products intake, all-cause mortality, and cause-specific mortality in Japan: the Jichi Medical School cohort study. Asia Pac J Public Health. 2015;27:531–41.
Nguyen HN, Miyagawa N, Miura K, Okuda N, Yoshita K, Arai Y, et al. Dietary tofu intake and long-term risk of death from stroke in a general population. Clin Nutr. 2018;37:182–8.
Nagata C, Wada K, Tmura T, Konoshi K, Goto Y, koda S, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr. 2017;105:426–31.
Katagiri R, Sawada N, Goto A, Yamaji T, Iwasaki M, Noda M, et al. Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study. BMJ. 2020;368:m34.
Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S. Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull. 1995;18:1387–91.
Namazi N, saneei P, Larijani B, Esmaillzadeh A. Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies. Food Funct. 2018;9:2576.
Yan Z, Zhang X, Li C, Jiao S, Dong W. Association between consumption of soy and risk of cardiovascular disease: a meta-analysis of observational studies. Eur J Prev Cardiol. 2017;24:735–47.
Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M, et al. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr. 2010;140:580–6.
Konishi K, Wada K, Yamakawa M, Goto Y, Mizuta F, Koda S, et al. Dietary soy intake is inversely associated with risk of type 2 diabetes in Japanese women but not in men. J Nutr. 2019;149:1208–14.
Tang J, wan Y, Zhao M, Zhong H, Zheng JS, Feng F. Legume and soy intake and risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020;00:1–12.
Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999;81:1248–56.
Nisho K, Niwa Y, Toyoshima H. Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study. Cancer Cause Control. 2007;18:801–8.
Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003;95:906–13.
Wada K, Nakamura K, Tamai Y, Tsuji M, Kawachi T, Hori A, et al. Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer. 2013;133:952–60.
Nagata C, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, et al. Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2014;44:282–5.
Sasazuki S, Inoue M, Shimazu T, Wakai K, Naito M, Nagata C, et al. Evidence-based cancer prevention recommendations for Japanese. Jpn J Clin Oncol. 2018;48:576–86.
Zhao TT, Jin F, Li JG, Xu YY, Dong HT, Liu Q, et al. Dietary isoflavones or isoflavone-rich food intakeand breast cancer risk: a meta-analysis of prospective cohort studies. Clin Nutr. 2019;38:136–45.
Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, Suzuki G, et al. A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control. 2004;15:911–20.
Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci. 2004;95:65–71.
Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomark Prev. 2007;16:538–45.
Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. J Clin Oncol. 2008;26:5923–9.
Applegate CC, Rowles III, JJ, Ranard KM, Joen S, Erdman Jr JW. Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients. 2018;40. https://doi.org/10.3390/nu10010040.
Ngoan LT, Mizoue T, Fujino Y, Tokui N, Yoshimura T. Dietary factors and stomach cancer mortality. Br J Cancer. 2002;87:37–42.
Tokui N, Yoshimura T, Fujino Y, Mizoue T, Hoshiyama Y, Yatsuya H, et al. Dietary habits and stomach cancer risk in the JACC study. J Epidemiol. 2005;15Suppl 2:S96–108.
Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, Sawada N, et al. Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr. 2012;95:147–54.
Wada K, Tsuji M, Tamura T, Konishi K, Kawachi T, Hori A, et al. Soy isoflavone intake and stomach cancer risk in Japan: from the takayama study. Int J Cancer. 2015;137:885–92.
Oba S, Nagata C, Shimizu N, Shimizu H, Kametani M, Takeyama N, et al. Soy product consumption and the risk of colon cancer: a prospective study in Takayama. Jpn Nutr Cance r. 2007;57:151–7.
Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan Public Health Center-based prospective study. Cancer Epidemiol Biomark Prev. 2008;17:2128–35.
Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, et al. Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurum Med J. 2004;51:141–9.
Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N, et al. Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case-control study in Japan. Int J Cancer. 2005;115:290–5.
Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizukami M, Tsugane S. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer. 2009;124:1644–9.
Ozasa K, Watanabe Y, Ito Y, Suzuki K, Tamakoshi A, Seki N, et al. Dietary habits and risk of lung cancer death in a large-scale cohort study (JACC study) in Japan by sex and smoking habit. Jpn J Cancer Res. 2001;92:1259–69.
Shimazu T, Inoue M, sasazuki S, Iwasaki M, Sawada N, Yamaji T, et al. Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr. 2010;91:722–8.
Wada K, Tsuji M, Tamura T, Konishi K, Goto Y, Mizuta F, et al. Soy isoflavone intake and bladder cancer risk in Japan: from the Takayama study. Cancer Epidemiol Biomark Prev. 2018;27:1371–5.
Sakauchi F, Khan MMH, Mori M, Kubo T, Fujino Y, Suzuki S, et al. Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer. 2007;57:138–45.
Budhathoki S, Iwasaki M, Sawada N, Yamaji T, Shimazu S, Sasazuki S, et al. Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study. BJOG 2015;122:304–11.
Akhlaghi M, Ghasemi NM, Riasatian M, Sadeghi F. Soy isoflavones prevent bone resorption and loss, a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019. https://doi.org/10.1080/10408398.2019.1635078.
Kojima A, Ikehara S, Kamiya K, Kajita E, Sato Y, Kouda K, et al. Natto intake is inversely associated with osteoporotic fracture risk in postmenopausal Japanese women. J Nutr. 2019;150:599–605.
Zhang X, Shu XO, Li H, Yang G, Li Q, Gao YT, et al. prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med. 2005;165:1890–5.
Koh WP, Wu AH, Wang R, Ang LW, Heng D, Yuan JM, et al. Gender-specific association between soy and risk of hip fracture in the Singapore Chinese Health Study. Am J Epidemiol. 2009;170:901–9.
Cauley JA, Chalhoub D, Kassem AM, Fuleihan Gel H. Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol. 2014;10:338–51.
Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsoy S, Kavousi M, et al. Use of plant-based therapies and menopausal symptoms. A systematic review and meta-analysis. JAMA. 2016;315:2554–63.
Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol. 2001;153:790–3.
Dunneram Y, Chung HF, Cade JE, Greenwood DC, Dobson AJ, Mitchell ES, et al. Soy intake and vasomotor menopausal symptoms among midlife women: a pooled analysis of five studies from InterLACE consortium. Eur J Clin Nutr. 2019;73:1501–11.
Cui C, Birru RL, Snitz B, Ihara M, Higashiyama A, Kakuta C, et al. Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2020;78:134–44.
Ozawa M, Ninomiya T, Ohara T, Doi Y, Uchida K, Shirota T, et al. Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr. 2013;97:1076–82.
Tomata Y, Sugiyama K, Kaiho Y, Honkura K, Watanabe T, Zhang S, et al. Dietary patterns and incident dementia in elderly Japanese: the Ohsaki cohort 2006 study. J Gerontol A Biol Sci Med Sci. 2016;71:1322–8.
Nakamoto M, Otsuka R, Nishita Y, Tange C, Tomida M, Kato Y, et al. Soy food and isoflavone intake reduces the risk of cognitive impairment in elderly Japanese women. Eur J Clin Nutr. 2018;72:1458–62.
Talael M, Feng L, Yuan JM, Pan A, Koh WP. Dairy, soy, and calcium consumption and risk of cognotove impairment: the Singapore Chinese Health study. Eur J Nutr. 2020;59:1541–52.
Nagata C. Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol. 2010;20:83–9.
Visentin S, Grumolato F, Nardelli GB, Di Camillo B, Grisan E, Cosmi E. Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis 2014;237:391–9.
Trichopoulos D. Hypothesis: does breast cancer originate in utero. Lancet 1990;335:939–40.
Lobaccaro JA, Trousson A. Environmental estrogen exposure during fetal life: a time bomb for prostate cancer. Endocrinology. 2014;155:656–8.
Messina M, Rogero MM, Fisberg, Waitzberg D. Health impact of childhood and adolescent soy consumption. Nutr Rev. 2017;75:500–1.
Setchell KDR, Brown NM, Lydeking-Olsen E. the clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577–84.
Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, et al. Effect of S-equol and soy isoflavones on heart and brain. Curr Cardiol Rev. 2019;15:114–35.
Zhang X, Gao YT, Yang G, Li H, Cai Q, Xiang YB, et al. Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol. 2012;41:1367–75.
Perez-Comago A, Appleby PN, Boeing H, Gil L, Kyrø C, Recceri F, et al. Circulating isoflavone and lignin concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls. Int J Cancer. 2018;143:2677–86.
Ashton EL, Dalais FS, Ball MJ. Effect of meat replacement by tofu on risk factors including copper induced LDL oxidation. J Am Coll Nutr. 2000;19:761–7.
Azadbakht L, Kimiaga M, Mehrabi Y, Esmailzadeh A, Hu FB, Willett WC. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr. 2007;98:807–13.
Ruscica M, Pavenello C, Gandini S, Gomaraschi M, Vitali C, Macchi C, et al. Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial. Eur J Nutr. 2018;57:499–51.
Sacks FM, Lichtenstein A, van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavons, and cardiovascular health. An American Heart Association Science Advisory for professionals from the nutrition committee. Circulation. 2006;113:1034–44.
This work is supported by the National Cancer Center Research and Development Funds (30-A-15), Japan.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nagata, C. Soy intake and chronic disease risk: findings from prospective cohort studies in Japan. Eur J Clin Nutr 75, 890–901 (2021). https://doi.org/10.1038/s41430-020-00744-x
European Journal of Clinical Nutrition (2021)